SCHEMBL6572534

SCHEMBL6572534

COc1cc(C(=O)C(=O)N(C)C(Cc2ccccc2)C(=O)N(Cc2ccc(F)cc2)C(CCc2ccncc2)CCc2ccncc2)cc(OC)c1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A4 P14672 2/20 0.39
SLC2A8 Q9NY64 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.37
MAPK1 P28482 1/20 0.37
LPAR1 Q92633 3/20 0.37
SLC2A1 P11166 3/20 0.37
ALDH1A1 P00352 1/20 0.37
KMT2A Q03164 3/20 0.37
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36
TUBB8 Q3ZCM7 1/20 0.36
TUBA3E Q6PEY2 1/20 0.36
TUBA1A Q71U36 1/20 0.36
TUBA1C Q9BQE3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6570385 1.00 SLC2A4 (0.39) SLC2A4SLC2A8L3MBTL1MAPK1LPAR1
SCHEMBL6573934 0.95 L3MBTL1 (0.40) L3MBTL1MAPK1LPAR1SLC2A1ALDH1A1
SCHEMBL6573929 0.95 L3MBTL1 (0.40) L3MBTL1MAPK1LPAR1SLC2A1ALDH1A1
SCHEMBL6572477 0.93 SLC2A1 (0.39) SLC2A4SLC2A8L3MBTL1SLC2A1KMT2A
SCHEMBL6570405 0.93 SLC2A1 (0.39) SLC2A4SLC2A8L3MBTL1SLC2A1KMT2A
Timcodar SCHEMBL3673444 0.92 L3MBTL1 (0.37) L3MBTL1MAPK1LPAR1SLC2A1ALDH1A1
SCHEMBL6570451 0.92 L3MBTL1 (0.37) L3MBTL1MAPK1LPAR1SLC2A1ALDH1A1
SCHEMBL6570448 0.92 L3MBTL1 (0.37) L3MBTL1MAPK1LPAR1SLC2A1ALDH1A1
Timcodar SCHEMBL1492143 0.92 L3MBTL1 (0.37) L3MBTL1MAPK1LPAR1SLC2A1ALDH1A1
SCHEMBL7177870 0.91 FKBP1A (0.40) L3MBTL1MAPK1LPAR1SLC2A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0797567-B1 NOVEL AMINO ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY VERTEX PHARMA (US) 2004-02-11 EP claimed
EP-1420009-A2 Novel amino acid derivatives with improved multi-drug resistance activity Vertex Pharmaceuticals Incorporated (US) 2004-05-19 EP disclosed
EP-0797567-B1 NOVEL AMINO ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY VERTEX PHARMA (US) 2004-02-11 EP disclosed
US-6284778-B1 NEUROTROPHIC AGENT VERTEX PHARMACEUTICALS INCORPORATED 2001-09-04 US disclosed
US-5543423-A USED IN MULTI-DRUG RESISTANCE CANCER THERAPY VERTEX PHARMACEUTICALS, INCORPORATED (US) 1996-08-06 US disclosed